1-10 of 10
Yi Huang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA)

Qinglei Gao, Jianqing Zhu, Weidong Zhao, Yi Huang, Ruifang An, Hong Zheng, Pengpeng Qu, Li Wang, Qi Zhou, Danbo Wang, Ge Lou, Jing Wang, Ke Wang, John Low, Beihua Kong, Abdul Malik Rozita, Lim Chun Sen, Rutie Yin, Xing Xie, Jihong Liu, Wei Sun, Jingya Su, Chunyi Zhang, Rongyu Zang, Ding Ma
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (11): 2278–2285.
https://doi.org/10.1158/1078-0432.CCR-21-3023
Published: 01 June 2022
View article titled, Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA)
Open the PDF for Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA) in another window
Includes: Supplementary data
Journal Articles

Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study

Xiaohua Wu, Jianqing Zhu, Jing Wang, Zhongqiu Lin, Rutie Yin, Wei Sun, Qi Zhou, Songling Zhang, Danbo Wang, Hong Shi, Yunong Gao, Yi Huang, Guiling Li, Xiuli Wang, Ying Cheng, Ge Lou, Qinglei Gao, Li Wang, Xiuping Du, Mei Pan, Xiyan Mu, Li Li, Miao Li, Song Mu, Beihua Kong
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (4): 653–661.
https://doi.org/10.1158/1078-0432.CCR-21-1186
Published: 15 February 2022
View article titled, Pamiparib Monotherapy for Patients with Germline <em>BRCA1/2</em>-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study
Open the PDF for Pamiparib Monotherapy for Patients with Germline <em>BRCA1/2</em>-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study in another window
Includes: Supplementary data
Journal Articles

High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib

Tzu-Hsuan Lin, Yu-Yun Shao, Soa-Yu Chan, Chung-Yi Huang, Chih-Hung Hsu, Ann-Lii Cheng
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16): 3678–3684.
https://doi.org/10.1158/1078-0432.CCR-14-1954
Published: 13 August 2015
View article titled, High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib
Open the PDF for High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib in another window
Journal Articles

YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activating JNK pathway

Wu Szu-Ying, Jih-Hwa Guh, Shiow-Lin Pan, Tzu-Hsuan Chen, Cho-Hwa Liao, Der-Yi Huang, Ya-Ling Chang, Fang-Yu Lee, Sheng-Chu Kuo, Che-Ming Teng
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22_Supplement): B45.
Published: 15 August 2014
View article titled, YC-1 induces apoptosis of human renal carcinoma A498 cells <em>in vitro</em> and <em>in vivo</em> through activating JNK pathway
Journal Articles

Enhancing Chemotherapy Response with Sustained EphA2 Silencing Using Multistage Vector Delivery

Haifa Shen, Cristian Rodriguez-Aguayo, Rong Xu, Vianey Gonzalez-Villasana, Junhua Mai, Yi Huang, Guodong Zhang, Xiaojing Guo, Litao Bai, Guoting Qin, Xiaoyong Deng, Qingpo Li, Donald R. Erm, Burcu Aslan, Xuewu Liu, Jason Sakamoto, Arturo Chavez-Reyes, Hee-Dong Han, Anil K. Sood, Mauro Ferrari, Gabriel Lopez-Berestein
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2013) 19 (7): 1806–1815.
https://doi.org/10.1158/1078-0432.CCR-12-2764
Published: 02 April 2013
View article titled, Enhancing Chemotherapy Response with Sustained EphA2 Silencing Using Multistage Vector Delivery
Open the PDF for Enhancing Chemotherapy Response with Sustained EphA2 Silencing Using Multistage Vector Delivery in another window
Journal Articles

Novel Oligoamine Analogues Inhibit Lysine-Specific Demethylase 1 and Induce Reexpression of Epigenetically Silenced Genes

Yi Huang, Tracy Murray Stewart, Yu Wu, Stephen B. Baylin, Laurence J. Marton, Brandy Perkins, Richard J. Jones, Patrick M. Woster, Robert A. Casero, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7217–7228.
https://doi.org/10.1158/1078-0432.CCR-09-1293
Published: 30 November 2009
View article titled, Novel Oligoamine Analogues Inhibit Lysine-Specific Demethylase 1 and Induce Reexpression of Epigenetically Silenced Genes
Open the PDF for Novel Oligoamine Analogues Inhibit Lysine-Specific Demethylase 1 and Induce Reexpression of Epigenetically Silenced Genes in another window
Includes: Supplementary data
Journal Articles

Moscatilin Induces Apoptosis in Human Colorectal Cancer Cells: A Crucial Role of c-Jun NH2-Terminal Protein Kinase Activation Caused by Tubulin Depolymerization and DNA Damage

Tzu-Hsuan Chen, Shiow-Lin Pan, Jih-Hwa Guh, Cho-Hwa Liao, Der-Yi Huang, Chien-Chih Chen, Che-Ming Teng
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (13): 4250–4258.
https://doi.org/10.1158/1078-0432.CCR-07-4578
Published: 01 July 2008
View article titled, Moscatilin Induces Apoptosis in Human Colorectal Cancer Cells: A Crucial Role of c-Jun NH<sub>2</sub>-Terminal Protein Kinase Activation Caused by Tubulin Depolymerization and DNA Damage
Open the PDF for Moscatilin Induces Apoptosis in Human Colorectal Cancer Cells: A Crucial Role of c-Jun NH<sub>2</sub>-Terminal Protein Kinase Activation Caused by Tubulin Depolymerization and DNA Damage in another window
Journal Articles

Characterization of CEBPA Mutations in Acute Myeloid Leukemia: Most Patients with CEBPA Mutations Have Biallelic Mutations and Show a Distinct Immunophenotype of the Leukemic Cells

Liang-In Lin, Chien-Yuan Chen, Dong-Tsamn Lin, Woei Tsay, Jih-Luh Tang, You-Chia Yeh, Hwei-Ling Shen, Fang-Hsien Su, Ming Yao, Sheng-Yi Huang, Hwei-Fang Tien
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1372–1379.
https://doi.org/10.1158/1078-0432.CCR-04-1816
Published: 02 March 2005
View article titled, Characterization of <em>CEBPA</em> Mutations in Acute Myeloid Leukemia: Most Patients with <em>CEBPA</em> Mutations Have Biallelic Mutations and Show a Distinct Immunophenotype of the Leukemic Cells
Open the PDF for Characterization of <em>CEBPA</em> Mutations in Acute Myeloid Leukemia: Most Patients with <em>CEBPA</em> Mutations Have Biallelic Mutations and Show a Distinct Immunophenotype of the Leukemic Cells in another window
Journal Articles

Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats

Sheng-Hong Tseng, Swei-Ming Lin, Jin-Cherng Chen, Yen-Hao Su, Hsin-Yi Huang, Chia-Kang Chen, Po-Yin Lin, Yun Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (6): 2190–2202.
https://doi.org/10.1158/1078-0432.CCR-03-0105
Published: 24 March 2004
View article titled, Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats
Open the PDF for Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats in another window
Journal Articles

A Novel Polyamine Analog Inhibits Growth and Induces Apoptosis in Human Breast Cancer Cells

Yi Huang, Erin R. Hager, Dawn L. Phillips, Valerie R. Dunn, Amy Hacker, Benjamin Frydman, John A. Kink, Aldonia L. Valasinas, Venodhar K. Reddy, Laurence J. Marton, Robert A. Casero, Jr., Nancy E. Davidson
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (7): 2769–2777.
Published: 01 July 2003
View article titled, A Novel Polyamine Analog Inhibits Growth and Induces Apoptosis in Human Breast Cancer Cells
Open the PDF for A Novel Polyamine Analog Inhibits Growth and Induces Apoptosis in Human Breast Cancer Cells in another window